We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nine Types of GI Infections Rapidly and Simultaneously Detected

By LabMedica International staff writers
Posted on 06 Apr 2010
A gastrointestinal (GI) panel can detect and differentiate nine types of GI infections simultaneously so that physicians can quickly identify patients who have severe, life-threatening infections.

The nine bacterial pathogens targeted in the GI panel include Clostridium difficile; Clostridium difficile toxin B gene; Campylobacter jejuni; Escherichia coli strain 0157; Listeria monocytogenes; Salmonella enterica; Staphylococcus aureus; Vibrio cholerae; and Vibrio parahaemolyticus.

The panel uses Diatherix Laboratories' (Huntsville, AL, USA) technology--target enriched multiplex polymerase chain reaction (Tem-PCR). More...
Tem-PCR can identify multiple pathogens, detect coinfections, and determine genetic drug resistance in a single result.

"The GI infection C. difficile is becoming more of a hospital threat than [methicillin resistant Staphylococcus aureus] MRSA, and since hospitals are currently limited in their testing methods, this is the ideal time to introduce our new panel," said Dennis Grimaud, chairman and CEO of, Diatherix Laboratories Inc.

The GI panel is the sixth standard testing panel produced by Diatherix. Other panels include tests for infectious disease; Staphylococcus differentiation; respiratory infections; human papillomavirus typing; and respiratory viruses.

Diatherix Laboratories is an emerging leader in infectious disease diagnostics and drug resistance-detection services. Using a multiplexing platform, the company has developed a series of molecular differential diagnostic services that enable speed and accuracy for health care providers in the identification of disease-producing pathogens, leading to appropriate treatment for patients.

Related Links:

Diatherix Laboratories





Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.